October 29, 2001 13:40
Stock Trading Swiftly Reacts to News
Jump to first matched term
VANCOUVER, BRITISH COLUMBIA--Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was DNAPrint genomics, Inc. (OTCBB: DNAP), trading over 12,100,000 shares in morning activity on news that the Company has 'solved' human eye color prediction from human DNA and developed its first commercial product, RETINOME(SM).
"Had we performed this work like others, on simple genetics terms,we would never have found the answer," stated Dr. Tony Frudakis, Ph.D., CEO and CSO of DNAPrint genomics, Inc. "It is because of our blend of computational, genetics and mathematical expertise that we are able to tease the complex genetics of eye color from the data, and it is because of this expertise that RETINOME(SM) is possible."
In other news, EquityAlert.com (www.equityalert.com) subscribers were recently alerted in real time on news that ZymeTx, Inc. (OTCBB: ZMTX) and San Antonio Lighthouse have formed a new manufacturing and distribution partnership that will supply the Company's patented rapid point-of-care influenza diagnostic test called ZstatFlu to all entities of the United States Federal Government.
Shares have subsequently traded over 1,700,000 shares and recorded a 51.1% price increase in only seven trading days, following the news.
This morning, alerts also included Cyclopss Corporation (OTCBB: OZON), trading over 1,000,000 shares after announcing that the Company has entered into a system development contract with the New Jersey based pharmaceutical company PHARMACIA (formerly Pharmacia Company). The contract calls for Cyclopss to utilize a proprietary ozone technology to develop a new process for decontamination, disinfection and aseptic maintenance in the manufacturing and packaging of certain PHARMACIA'S products.
In morning trading, OZON share volume has increased four-fold over the daily average following release of this news.
For free real-time email alerts on these and other publicly traded US and Canadian stocks, and mutual funds, please visit www.EquityAlert.com. |
